AMR Action Fund

This account is verified. Learn more

@AMRActionFund

We are a groundbreaking venture fund investing approximately US$1 billion to bring 2 to 4 new antimicrobials to patients by the end of the decade.

Boston, MA amractionfund.com Joined June 2020

298 Following 4K Followers 2.3K Posts

Latest posts 5

AMR Action Fund @AMRActionFund Oct 28

"Unless policymakers address the underlying market failure, AI will generate promising antibiotic candidates that nobody is willing to finance or able to develop." #AMR via @Forbes forbes.com/sites/the-prot…

www.forbes.com This Startup Wants To Catch AI’s Mistakes A flight recorder for wayward AI systems. The space industry’s record investments. AI spending warnings. All that and more in this week’s Prototype.

AMR Action Fund @AMRActionFund Oct 27

New @CDCgov report on #AMR in US: ~9.7M infections and more than 50k deaths annually, with substantial costs (~$12 billion) to health care system. Learn more here: arpsp.cdc.gov/artr

AMR Action Fund @AMRActionFund Oct 1

Americans are living longer than ever, and more of us are living well into older age. But those gains are increasingly at risk due to drug-resistant infections #AMR futureofpersonalhealth.com/infectious-dis…

www.futureofpersonalhealth.com AMR: the Growing Threat to the Elderly Antimicrobial resistance (AMR) affects millions every year, and America's seniors are on the frontlines. Closing gaps in detection, prevention, and treatment is key to protecting older adults from...

AMR Action Fund @AMRActionFund Sep 3

Philanthropy, however, can take drug development only so far. For a problem as significant and costly as antimicrobial resistance, the type of innovation we need will emerge only if policymakers create the conditions for it to flourish cidrap.umn.edu/antimicrobial-… #AMR

www.cidrap.umn.edu COMMENTARY: We must address the market challenges behind microbiome-sparing antibiotics

AMR Action Fund @AMRActionFund Aug 13

"If policymakers want antibiotics that are more precise and less disruptive to beneficial bacteria, they must create the market conditions that make them investable." #AMR

CIDRAP @CIDRAP Aug 13

COMMENTARY: We must address the market challenges behind microbiome-sparing antibiotics

Interest in antimicrobial drugs designed to minimize microbiome disruption is growing, but we need good policy to support them.

Read full piece by Henry Skinner, PhD: bit.ly/3UgVfa5

View quoted post on X